glp-1 atrial fibrillation Association of glucagon-like peptide-1 receptor agonists with fibrillation, cardiac arrest, and ventricular fibrillation: Casual evidence from a drug target Mendelian randomization | Diabetology & Metabolic Syndrome The Liraglutide Effects in Atrial

bit.ly/3RejWzg Members of $MED's Scientific and Clinical Affairs team and Medifasts Scientific Advisory Board recently published an article in Diabetes, Obesity and Metabolism, highlighting GLP-1 discontinuation rates

Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist

Electrolyte+ Hydration + energy support

Sources Review of GLP-1 Medicines for Obesity and Symptoms in Menopause Fat Mass Changes During Menopause: a Metaanalysis The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society Vasomotor Symptoms Across the Menopause Transition: Differences Among Women The Impact of the Menopausal Transition on Body Composition and Abdominal Fat Redistribution Wilding JPH et al